Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vaxcyte (PCVX) Share-based Compensation (2019 - 2026)

Vaxcyte (PCVX) has 8 years of Share-based Compensation data on record, last reported at $38.0 million in Q1 2026.

  • On a quarterly basis, Share-based Compensation rose 24.0% to $38.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $146.2 million, a 49.47% increase, with the full-year FY2025 number at $138.8 million, up 63.69% from a year prior.
  • Share-based Compensation reached $38.0 million in Q1 2026 per PCVX's latest filing, up from $36.0 million in the prior quarter.
  • Over the last five years, Share-based Compensation for PCVX hit a ceiling of $38.0 million in Q1 2026 and a floor of $2.7 million in Q3 2022.
  • A 5-year average of $18.6 million and a median of $17.6 million in 2024 define the central range for Share-based Compensation.
  • Peak YoY movement for Share-based Compensation: soared 500.2% in 2022, then grew 0.29% in 2023.
  • Tracing PCVX's Share-based Compensation over 5 years: stood at $7.0 million in 2022, then skyrocketed by 90.44% to $13.3 million in 2023, then surged by 82.57% to $24.4 million in 2024, then skyrocketed by 47.71% to $36.0 million in 2025, then increased by 5.46% to $38.0 million in 2026.
  • Business Quant data shows Share-based Compensation for PCVX at $38.0 million in Q1 2026, $36.0 million in Q4 2025, and $35.3 million in Q3 2025.